Sugammadex Injection, Solution
Product Images NDC 43598-925

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 43598-925). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

200mgcarton (200mgcarton)

Packaging label for Sugammadex Injection 200 mg/2 mL (100 mg/mL), an intravenous solution. The carton indicates it contains 10 single-dose 2 mL vials and instructs to discard unused portions. Distributed by Dr. Reddy's Laboratories Inc., made in India, with storage and dosage information included on the label.*

FDA Label Image

500mgcarton (500mgcarton)

Packaging label for Sugammadex Injection 500 mg/5 mL (100 mg/mL) by Dr. Reddy's Laboratories Inc. The label indicates the product is for intravenous use only, supplied in 10 single-dose 5 mL vials per carton, with instructions to discard unused portions. The label includes storage information, dosage form, and manufacturer details, along with barcodes and lot codes.*

FDA Label Image

Chemical Structure (Chemical Structure1)

Chemical structure diagram of the active ingredient sugammadex, showing its complex cyclic molecular framework with multiple hydroxyl, carboxyl, and sulfur groups.*

FDA Label Image

Chemical Structure (Chemical Structure2)

Chemical structure of Sugammadex shown as a complex cyclic molecular diagram with multiple oxygen, sulfur atoms, hydroxyl groups, and sodium carboxylate substituents arranged in a large ring.*

FDA Label Image

Figure 1 (Figure1)

A cumulative recovery rate chart comparing the time to recovery in minutes for sugammadex 2 mg/kg and neostigmine 0.05 mg/kg. The graph shows a faster recovery rate with sugammadex, reaching near complete recovery much earlier than neostigmine over a 120-minute period. Median recovery times are provided in the graph legend.*

FDA Label Image

Figure 2 (Figure2)

A cumulative recovery rate curve graph comparing the recovery times for Sugammadex 2 mg/kg and Neostigmine 0.05 mg/kg. The X-axis shows time to recovery in minutes from 0 to 120, and the Y-axis shows cumulative recovery rate from 0.0 to 1.0. The graph displays faster recovery with Sugammadex compared to Neostigmine. Included is a median recovery time summary box and a legend explaining the line styles for the two drugs.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.